[go: up one dir, main page]

Baidoo et al., 1994 - Google Patents

Bifunctional Chelator for Facile Preparation of Neutral Techetium Complexes.

Baidoo et al., 1994

Document ID
14326409208319565477
Author
Baidoo K
Lever S
Scheffel U
Publication year
Publication venue
Bioconjugate Chemistry

External Links

Snippet

Materials and Methods. Solvents and chemicals were reagent grade and used as received unless specified. Glucoheptonate kits (Glucoscan) were purchased from Dupont, N. Billerica, MA.[99mTc] NaTc04 was obtained as a saline solution from a [99] Mo/[99m, Tc generator …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

Similar Documents

Publication Publication Date Title
CA1225996A (en) Brain imaging radiopharmaceuticals
Mastrostamatis et al. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents
US5095111A (en) Thiolactone bifunctional chelating agents for diagnostic and therapeutic products
WO2005077962A2 (en) Crowned dithiocarbamate metal complexes and methods for their use
Baidoo et al. Synthesis of a diamine dithiol bifunctional chelating agent for incorporation of technetium-99m into biomolecules
US5196515A (en) Thiolactone bifunctional chelating agents for diagnostic and therapeutic products
Baidoo et al. Bifunctional Chelator for Facile Preparation of Neutral Techetium Complexes.
Jones Jr et al. Synthesis and biodistribution of a new 99mtechnetium fatty acid
Mach et al. Synthesis and biodistribution of a new class of 99mTc-labeled fatty acid analogs for myocardial imaging
Ohmomo et al. New conformationally restricted technetium-99m N2S2 complexes as myocardial perfusion imaging agents
NZ523663A (en) Radiopharmaceutical for diagnostic imaging containing a technetium-99M nitride heterocomplex
Chiotellis et al. Comparative evaluation of 99mTc-labeled aminothiols as possible brain perfusion imaging agents
US5079346A (en) Gallium-labelled imaging agents
WO2006080993A1 (en) Novel cationic metal complex radiopharmaceuticals
US4885100A (en) Tris(isonitrile)copper(I) adducts for preparing radionuclide complexes
Zhuang et al. Neutral and stereospecific Tc-99m complexes:[99mTc] N-benzyl-3, 4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT)
Najafi et al. Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclides
NZ269642A (en) Tris(isonitrile)copper (i) sulphate complex [cu(cnr)<sub>3</sub>]<sub>2</sub>[so<sub>4</sub>], use in radionuclide compositions
Hosotani et al. Search for 99mTc labeled DTS bifunctional radiopharmaceutical: role of functional groups in myocardial accumulation
Stepniak-Biniakiewicz et al. A new, general synthetic route to multidentate N, S ligands for use in technetium-99m radiopharmaceuticals. Preparation of diamido disulfur, diamino dithiol, and tripodal N3S3 prototypes. Comparative biodistributions of [99mTcVO-DADS]-analogs which contain 5, 5, 5-and 5, 7, 5-membered chelate ring systems
Lever et al. Pulmonary accumulation of neutral diamine dithiol complexes of technetium‐99m
Papadopoulos et al. 99mTc-DADT complexes substituted with heterocyclic amines: effect of substitution on in vivo reactivity
Fields et al. Synthesis and radiolabeling of technetium radiopharmaceuticals based on N‐substituted iminodiacetic acid: Effect of radio‐labeling conditions on radiochemical purity
Belhadj-Tahar et al. Technetium labeling of bi, tri and tetradentate ligands derived from 2-aminocyclopentene-1-dithiocarboxylic acid: Characterization and biodistribution of their oxo and nitrido 99mtechnetium complexes
John et al. Preparation, radiolabeling and biodistribution of a new class of bisaminothiol (BAT) ligands as possible imaging agents